CAMBRIDGE, Mass., June 09, 2025--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNA interference (RNAi) therapeutics company, today announced that the European Commission (EC) has ...

NICE has reversed its stance on Alnylam’s gene-silencing drug Onpattro for rare disease hATTR amyloidosis, backing NHS funding.

Alnylam has been a pioneer in hereditary ATTR amyloidosis, getting approval in 2018 for the first drug to treat the rare disease, and has now launched a digital companion to help patients track ...

Indications In the EU, AMVUTTRA ® (vutrisiran) is indicated for the treatment of: hereditary transthyretin amyloidosis in adult patients with stage 1 or stage 2 polyneuropathy (hATTR-PN).

The first white ribbon campaign to raise awareness of lung cancer in Ireland has just launched thanks to the determined efforts of two patients described as "absolute powerhouses" in Cork and ...

Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.

The Green Township Police Department celebrated the opening of its new police station with a ribbon-cutting ceremony on Friday.

Prothena is laying off almost two-thirds of its workforce as the Irish biotech navigates the fallout from giving up on its failed amyloidosis drug.

Springfield celebrated the ribbon cutting of the renovated Silver Springs Park Pavillion and Amphitheatre Friday evening.

It’s been years in the making, and now, the OG&E Coliseum is finally open. Oklahoma City Mayor David Holt said it will be an economic powerhouse for the city.